Joe Lonsdale Quotes

We need 10,000 genomes, not 100, to start to understand the link between genetics, disease and wellness.

New drugs and surgical techniques offer promise in the fight against cancer, Alzheimer's, tuberculosis, AIDS, and a host of other life-threatening diseases. Animal research has been, and continues to be, fundamental to advancements in medicine.

Now, as the world's scientists focus with increasing intensity on transforming the genetic codes of every living creature into information that can be used to treat and ultimately prevent disease, Shenzhen is home to a different kind of factory: B.G.I., formerly called Beijing Genomics Institute, the world's largest genetic-research center.

In 15 years, we've raised $225 million, sequenced the myeloma genome, and opened 45 trials of 23 drugs - six approved by the FDA - which have doubled the life span of multiple myeloma patients. I've taken both Velcade and Revlimid, which we helped develop.

Once we all have our genomes, some of these extremely rare diseases are going to be totally predictable.

If genetic research doesn't seemed to have lived up to its therapeutic promise, it's because sequencing is just too slow and expensive.

We live in a time when the words impossible and unsolvable are no longer part of the scientific community's vocabulary. Each day we move closer to trials that will not just minimize the symptoms of disease and injury but eliminate them.

We can get much better outcomes from people if we understand the genetic basis of the exact cancer that they have, what interventions might be most effective against it, what's worked in the past and what hasn't.

An important finding is that by determining the genome sequences of an entire family, one can identify many DNA sequencing errors and thus greatly increase the accuracy of the data. This will ultimately help us understand the role of genetic variations in the diagnosis, treatment, and prevention of disease.

Even if we never cure a single disease, the Human Genome Project and other ventures will have been worth it.

We now have the ability to explore many new treatments for many diseases. However we do not have enough money to explore them all…. I measure time by the number of patients who die each day as the result of diseases that we do not have enough money to develop cures for. We have the tools. We need the money.

I'm hoping that these next 20 years will show what we did 20 years ago in sequencing the first human genome, was the beginning of the health revolution that will have more positive impact in people's lives than any other health event in history.

We'll be investing in basic science research with the goal of curing disease.

We once thought of cancer as an incurable disease; then we started treating it.

We are still working with an incomplete compass. The time is right to bring the full power of genomics to bear on the problem of cancer.

And of course, identifying all human genes and proteins will have great medical significance.

Medical science has proven time and again that when the resources are provided, great progress in the treatment, cure, and prevention of disease can occur.

Scientists have established huge numbers of links between particular diseases and snippets of DNA, but in the great majority of cases, this has not yet been translated into treatments that can help cure patients. These treatments will come - tomorrow, or the day after.

In Wisconsin, We're at the forefront of research that might one day bring cures for diseases like Parkinsons and Alzheimers, and we must seize its great potential.

If our society continues to support basic research on how living organisms function, it is likely that my great grandchildren will be spared the agony of losing family members to most types of cancer.

By acquiring Biovex, we're continuing the transformation of Amgen into a company that supports therapeutic oncology as well as supportive care oncology.

Research is what it's going to take to cure all these diseases.

Heart disease continues to be the number one killer; cancer, the number 2 killer, not far behind. The tragic aspect of these deadly diseases is that they could all be cured, I do believe, if we had sufficient funding.

With Halcyon's technology, the pool of genetic information will grow by orders of magnitude in the course of months, offering the first real chance at cures for cancer and other previously intractable diseases.

We have a responsibility to promote stem cell research which could lead to treatments and cures for diseases affecting millions of Americans.